Antinociceptive effect of novel pyrazolines in mice

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 10, 2004, Pages 1531-1540

  Tabarelli, Z ^a   Rubin, M A ^a   Berlese, D B ^a   Sauzem, P D ^a   Missio, T P ^a   Teixeira, M V ^a   Sinhorin, A P ^a   Martins, M A P ^a   Zanatta, N ^a   Bonacorso, H G ^a   Mello, C F ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antinociception; Immobility; Open field test; Pyrazole derived compounds; Rotarod test; Tail immersion test

Indexed keywords

3 (1 ETHOXYETHYL) 5 ETHOXYCARBONYL 1 METHYL 1H PYRAZOLE; 3 (1 ETHOXYETHYL) 5 ETHOXYCARBONYL 1 PHENYL 1H PYRAZOLE; 3 (1 ETHOXYETHYL) 5 ETHOXYCARBONYL 1H PYRAZOLE; 3 ETHOXYMETHYL 5 ETHOXYCARBONYL 1 METHYL 1H PYRAZOLE; 3 ETHOXYMETHYL 5 ETHOXYCARBONYL 1 PHENYL 1H PYRAZOLE; 3 ETHOXYMETHYL 5 ETHOXYCARBONYL 1H PYRAZOLE; ANTINOCICEPTIVE AGENT; MORPHINE DERIVATIVE; NALOXONE; OPIATE RECEPTOR; PYRAZOLE DERIVATIVE; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; IMMERSION; IMMOBILIZATION; LATENT PERIOD; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; OPEN FIELD TEST; TAIL; WITHDRAWAL REFLEX;

ANIMALIA;

EID: 5644245386     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004001000013     Document Type: Article

References (39)

1. Borne RF (1995). Nonsteroidal anti-inflammatory drugs. In: Foye WO, Lemke TL & Williams DA (Editors), Principles of Medicinal Chemistry. Williams & Wilkins, Baltimore, MD, USA.
2. Vane JR (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biology, 231: 232-235.
3. Ferreira SH (1972). Prostaglandins, aspirin-like drugs and analgesia. Nature, 240: 200-203.
4. Ferreira SH, Lorenzetti BB & Correa FM (1978). Central and peripheral antialgesic action of aspirin-like drugs. European Journal of Pharmacology, 53: 39-48.
5. Ku EC, Lee W, Kothari HV & Scholar DW (1986). Effect of diclophenac sodium on the arachidonic acid cascade. American Journal of Medicine, 80: 18-23.
6. Campos C, Gregorio R, Garcia-Nieto R, Gago F, Ortiz P & Alemany S (1999). Regulation of cyclooxygenase activity by metamizol. European Journal of Pharmacology, 378: 339-347.
7. Ferreira SH, Moncada S & Vane JR (1973). Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. British Journal of Pharmacology, 49: 86-97.
8. Flower RJ & Vane JR (1972). Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of acetaminophen. Nature, 240: 410-411.
9. Vane JR (1987). The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action. Drugs, 33: 18-27.
10. Millan MJ (1999). The induction of pain: an integrative review. Progress in Neurobiology, 57: 1-164.
11. Tortorici V & Vanegas H (1994). Putative role of medullary off- and on-cells in the antinociception produced by dipyrone (metamizol) administered systemically or microinjected into PAG. Pain, 57: 197-205.
12. Tortorici V, Vasquez E & Vanegas H (1996). Naloxone partial reversal of the antinociception produced by dipyrone microinjected into periaqueductal gray of rats. Possible involvement of medullary off- and on-cells. Brain Research, 725: 106-110.
13. de Souza FR, Fighera MR, Lima TTF, Bastiani J, Barcellos IB, Almeida CE, Oliveira MR de, Bonacorso HG, Flores AE & Mello CF de (2001). 3-Methyl-5-hydroxy-5-trichlomethyl-1H-1-pyrazolcarboxyamide induces antinociception. Pharmacology, Biochemistry, and Behavior, 68: 525-530.
14. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16: 109-110.
15. Martins MAP, Sinhorin AP, Zimmermann NEK, Zanatta N, Bonacorso HG & Bastos GP (2001). A convenient synthesis of 5-trichloro-methyl-5-hydroxy-3-heteroalkyl-4,5-dihydroisoxazoles. Synthesis, 13: 1959-1964.
16. Martins MAP, Sinhorin AP, Rosa A et al. (2002). Regiospecific allylic mono- and dibromination of 4-methoxy-1,1,1-trihalo-3-alken-2-ones and 5-methoxy-1,1,1,2,2-pentafluoro-4-hexen-2-one, and their applications to the synthesis of heterocycles. Synthesis, 16: 2353-2358.
17. Siegfried B, Netto CA & Izquierdo I (1987). Exposure to novelty induces naltrexone-reversible analgesia in rats. Behavioral Neuroscience, 101: 436-438.
18. Janssen PAJ, Niemegeers CJE & Dony JGH (1963). The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneimittel-Forschung (Drug Research), 15: 502-507.
19. Tsuda M, Suzuki T, Misawa M & Nagase H (1996). Involvement of the opioid system in the anxiolytic effect of diazepam in mice. European Journal of Pharmacology, 307: 7-14.
20. Rubin MA, Albach CA, Berlese DB, Bonacorso HG, Bittencourt SRC, Queiroz CMT, Maixner AE & Mello CF (2000). Anxiolytic-like effects of 4-phenyl-2-trichloromethyl-3H-1,5-benzodiazepine hydrogen sulfate in mice. Brazilian Journal of Medical and Biological Research 33: 1069-1073.
21. Tabarelli Z, Berlese DB, Sauzem PD, Mello CF & Rubin MA (2003). Antinociceptive effects of Cremophor EL orally administered to mice. Brazilian Journal of Medical and Biological Research, 36: 119-123.
22. Akman H, Aksu F, Gultekin I, Ozbeck H, Oral U, Doran F & Baysal F (1996). A possible central antinociceptive effect of dipyrone in mice. Pharmacology, 53: 71-78.
23. Ora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, Miner LL & Uhl GR (1997). Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proceedings of the National Academy of Sciences, USA, 94: 1544-1549.
24. Endoh T, Matsuura H, Tajima A et al. (1999). Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist. Life Sciences, 65: 1685-1694.
25. Kovelowski CJ, Bian D, Hruby VJ, Lai J, Ossipov MH & Porreca F (1999). Selective opioid delta agonists elicit antinociceptive supraspinal/spinal synergy in the rat. Brain Research, 843: 12-17.
26. Tseng LF, Narita M, Suganuma C, Mizoguchi H, Ohsawa M, Nagase H & Kampine JP (2000). Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse, Journal of Pharmacology and Experimental Therapeutics, 292: 576-583.
27. Takeda H, Tsuji M & Matsumiya T (1998). Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. European Journal of Pharmacology, 350: 21-29.
28. Grevert P & Goldstein A (1977). Some effects of naloxone on behavior in the mouse. Psychopharmacology, 53: 111-113.
29. Katz RJ & Gelbart J (1978). Endogenous opiates and behavioral responses to environmental novelty. Behavioral and Neural Biology, 24: 338-348.
30. Katz RJ (1979). Naltrexone antagonism of exploration in the rat. International Journal of Neuroscience, 9: 49-51.
31. Rotta FT, Mello CF, Rocha JBT & Souza DOG (1988). Early undernutrition blocks the effect of naltrexone on rat exploratory behavior. Brazilian Journal of Medical and Biological Research, 21: 305-312.
32. Rocha JBT & Mello CF (1994). Handling during suckling alters rat behavior but does not reverse the deleterious effects of undernutrition on naltrexone-induced inhibition of exploratory activity. International Journal for Vitamin and Nutrition Research, 64: 152-156.
33. Marita M, Suzuki T, Funada M, Misawa M & Nagase H (1993). Involvement of δ-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacology, 111: 423-426.
34. Marita M, Takahashi Y, Takamori K, Funada M, Suzuki S, Misawa M & Nagase H (1993). Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Japanese Journal of Pharmacology, 62: 15-24.
35. Mansour A, Fox CA, Akil H & Watson SJ (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends in Neurosciences, 18: 22-29.
36. Spanagel R (1995). Modulation of drug-induced sensitization processes by endogenous opioid systems. Behavioural Brain Research, 70: 37-49.
37. Matsumoto RR, Brinsfield KH, Patrick RL & Walker JM (1988). Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. Journal of Pharmacology and Experimental Therapeutics, 246: 196-203.
38. Pan ZZ (1998). mu-Opposing actions of the kappa-opioid receptor. Trends in Pharmacological Sciences, 19: 94-98.
39. Kuzmin A, Sandin J, Terenius L & Ögren S (2000). Dose- and time-dependent bimodal effects of κ-opioid agonists on locomotor activity in mice. Journal of Pharmacology and Experimental Therapeutics, 295: 1031-1042.